The WashU Medicine Amyloid Center of Excellence has been selected as one of just 10 centers nationwide to participate in the American Heart Association’s ATTR-CM Discovery Initiative, a three-year program aimed at transforming care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
Amyloid Center of Excellence Selected for AHA ATTR-CM Discovery Initiative (Links to an external site)














































